Order Article Reprints

Volkers A, Löwenberg M, Braad M, Abeling Y, Gecse K, Berkers N, Montazeri N, D’Haens G. Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting. Diagnostics. 2023; 13(10):1712. https://doi.org/10.3390/diagnostics13101712

Volkers, Adriaan, Mark Löwenberg, Marlou Braad, Yara Abeling, Krisztina Gecse, Nicole Berkers, Nahid Montazeri, and Geert D’Haens. 2023. "Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting" Diagnostics 13, no. 10: 1712. https://doi.org/10.3390/diagnostics13101712

Volkers, A., Löwenberg, M., Braad, M., Abeling, Y., Gecse, K., Berkers, N., Montazeri, N., & D’Haens, G. (2023). Validation Study of Novel Point-of-Care Tests for Infliximab, Adalimumab and C-Reactive Protein in Capillary Blood and Calprotectin in Faeces in an Ambulatory Inflammatory Bowel Disease Care Setting. Diagnostics, 13(10), 1712. https://doi.org/10.3390/diagnostics13101712